CCNB1 and esophageal squamous cell carcinoma: Moreover, the active antitumor drug dracorhodin perchlorate (DP) induced the G2/M phase cell cycle arrest of ESCC cells (ECA109, EC9706, and KYSE410) by down‐regulating CCNB1 [29].